A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image Guided Stereotactic Body Radiotherapy (SBRT) in the Treatment of Metastatic Anaplastic Thyroid Cancer. Lee NY, Riaz N, Wu V, Brinkman T, et al. Thyroid 2022 May 6. doi: 10.1089/thy.2022.0050.

Read + Share

Amedeo Smart

Independent Medical Education